MORGAN STANLEY - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 25 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$1,0001,978
+54.8%
0.00%
Q1 2022$0
-100.0%
1,2780.0%0.00%
Q4 2021$1,0000.0%1,2780.0%0.00%
Q3 2021$1,000
-50.0%
1,2780.0%0.00%
Q2 2021$2,000
-33.3%
1,2780.0%0.00%
Q1 2021$3,0000.0%1,2780.0%0.00%
Q4 2020$3,0001,2780.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q1 2022
NameSharesValueWeighting ↓
Campion Asset Management 90,612$34,0000.03%
Virtu Financial LLC 112,255$42,0000.00%
Ratio Wealth Group 22,500$8,4600.00%
TWO SIGMA SECURITIES, LLC 118,890$45,0000.00%
Renaissance Technologies 1,801,200$677,0000.00%
Advisory Services Network, LLC 50,525$19,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
JANE STREET GROUP, LLC 49,730$19,0000.00%
UBS Group AG 54,955$21,0000.00%
IFP Advisors, Inc 4,000$26,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders